Clinical trial
Effects of Tibolone and PPARα-agonist on HDL Metabolism in Postmenopausal Women
NCT00809068 is registered in ClinicalTrials.gov with Keogh Institute for Medical Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Tibolone and PPARα-agonist on HDL Metabolism in Postmenopausal Women
- Lead sponsor
- Keogh Institute for Medical Research
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2005
- Completion date
- October 31, 2009
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hdl cholesterol